Decision making in the immune system: Regulation of B-cell fate by antigen-receptor signals

By H. Niiro, E. Clark. Nature reviews. Immunology, 2002

706 citations recorded by the source corpus.

Subfields: Immunology

View Paper: https://www.semanticscholar.org/paper/12472cd95fd261999b01aa6e2ea1ba816210e99a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Advani
2. R. Furman
3. J. Buggy
4. J. Sharman
5. R. Izumi
6. Sonali M. Smith
7. B. Grant
8. B. Chang

Citations in the corpus

• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. (2003, neutral): “Median age, y (range) 32 (14-59) 64 (20-92)”
• Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies. (2013, background): “Signaling from the B-cell antigen receptor (BCR) regulates multiple cellular processes, including proliferation, differentiation, apoptosis, and cell migration, and is essential for normal B-cell development and survival.(1,2) The BCR pathway is implicated in the pathogenesis of several B-cell malig”